Empresas — Amsterdam Molecular Therapeutics

Empresas — Amsterdam Molecular Therapeutics

• Amsterdam Molecular Therapeutics Reports Half-Year Results 2011‏

  Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2011. Leer el resto

  El 25 agosto 2011 por   Fat
  NONE

• Amsterdam Molecular Therapeutics Reports Half-Year Results 2010

  Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the fieldof human gene therapy, today reported its results for the first half year of2010. Leer el resto

  El 31 agosto 2010 por   Fat
  

• Amsterdam Molecular Therapeutics consigue prometedores datos en el estudio de...

  

  Amsterdam Molecular Therapeutics (Euronext: AMT), líder en el campo de la terapia genética humana, ha anunciado hoy los datos preclínicos positivos de un estudi... Leer el resto

  El 22 mayo 2010 por   Fat
  NONE

• AMT receives orphan drug designation from the U.S. Food and Drug Administration...

  Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT), a leader in the field of human gene therapy, announced today that the U.S. Leer el resto

  El 24 septiembre 2010 por   Fat
  

• AMT Nominates Three High Profile Executives to Supervisory Board and Expands...

  Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it has nominated three international... Leer el resto

  El 10 agosto 2010 por   Fat